Yongjian Wu Email

Chief Development Officer . MBrace Therapeutics

Current Roles

Employees:
34
Revenue:
$6.4M
About
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.
MBrace Therapeutics Address

San Diego, CA
United States
MBrace Therapeutics Email

Past Companies

MBrace Therapeutics, Inc.Chief Development Officer
Ansun Biopharma, Inc.VP of CMC
MabPlex USAChief Operating Officer